Supplemental Figure Legends
-Phos-tag, followed by immunoblotting with the anti-MBD4 antibody. By treatment with alkaline phosphatase, shifts in the mobility of MBD4 were suppressed. Table S1 . Differentially expressed genes (DEGs) identified from both RNA-sequencing and microarray
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Supplemental Experimental Procedures
Cell culture MCF-7 cells were cultured in Dulbecco's modified Eagle's medium (DME/F-12, Thermo Scientific) supplemented with 1% penicillin/streptomycin (Thermo Scientific), 10 µg/ml insulin (Gibco), and 10% heat inactivated fetal bovine serum (Thermo Scientific) at 37°C in 5% CO2. T47D cells were cultured in the same conditions in RPMI1640 (RPMI1640, Thermo Scientific) supplemented with 1% penicillin/streptomycin (Thermo Scientific) and 10% heat inactivated fetal bovine serum. RON and MSP were stably expressed in MCF7 cells by retroviral infection (Liu et al., 2011) . MCF7-RON/MSP cells were maintained in MCF7 medium supplemented with 0.2 µg/ml puromycin and 50 µg/ml hygromycin. MCF7 and T47D cell lines were infected with lentiviral constructs that direct the synthesis of shRNA (based on PLKO.1 but with a neo resistant cassette substituted for the puromycin resistant cassette) and selected by the addition of 1 mg/mL G418 48 hours later.
In vivo metastasis
All animal procedures were reviewed and approved by the University of Utah by oral gavage every other day until a tumor diameter of 1.2-1.5 cm was reached. Mice were killed and analyzed for metastasis histologically.
DNA and RNA isolation procedures
Genomic DNA for bisulfite modification was isolated using the DNeasy Blood Kit (Qiagen). Total RNA for gene expression analysis by microarray and quantitative RT-PCR was isolated with the RNeasy Kit (Qiagen) and tested for integrity on RNA 6000
NanoChips using an Agilent 2100 Bioanalyzer.
DNA methyltransferase (Dnmt) activity assay.
We quantified the total Dnmt activity levels using a colorimetric assay with the EpiQuik DNA Methyltransferase Activity Assay kit (Epigentek Group). In this assay, Dnmt transfers a methyl group from S-adenosylmethionine (AdoMet) to a cytosine in the DNA substrate. Methylated DNA was probed using an anti-5-methylcytosine antibody. The levels of methylated DNA, which were proportional to the enzymatic activity, were then colorimetrically quantified and expressed as absorbance units 450 nm•h−1•mg protein−1.
Quantitative real-time RT-PCR
Total RNA (1µg) was primed with oligo (dT) primers and converted into cDNA with RevertAid First Strand cDNA Synthesis Kit (Fermentas). SYBR green-based real time PCR was performed with a Roche LightCycler system, and the reaction mix contained 1X SYBR green master mix (SABiosciences) and 0.5 µM each of the forward and reverse primers in a volume of 25 µl. PCR cycling consisted of 95˚C for 10 min, then 30 cycles of 95˚C for 10 sec, 60˚C for 30 sec, 72˚C for 10 sec, followed by a melting-curve analysis. All PCR primers used are available on request.
Expression array hybridization and data analysis
Triplicate biological replicates of hybridization were performed for each cell line. The Agilent Quick Amp Labeling Kit is used to generate fluorescently labeled cRNA for onecolor microarray hybridizations. Agilent RNA spike-in controls are combined with input total RNA samples (50 to 1000 ng). The polyadenylated fraction of the total RNA sample is primed with oligo dT/T7 RNA polymerase promoter oligonucleotide sequences and cDNA synthesis is accomplished through the addition of MMLV-RT. information is used to perform calculations that include feature intensities, background measurements and statistical analyses. Data generated by the software is recorded as a tab-delimited text file. The text data were analyzed using the AgilentFilter and Genesifter software. Differential gene expression was evaluated using the t-test (p<0.01) and Benjamini and Hochberg correction. The threshold was set at 2-fold change for both upregulated and downregulated genes. Specific differentially expressed genes were confirmed by RT-qPCR.
Whole-Genome Bisulfite Sequencing (WGBS)
Library construction was performed using the Illumina TruSeq. 
Computational analytical method for WGBS
The software packages used in this analysis are open source and available from the USeq (http://useq.sourceforge.net/usageBisSeq.html) project website (Nix et al., 2010) .
SAM alignments were generated from Illumina Fastq files aligned to the human hg19 genome using Novocraft's novoalign aligner (http://www.novocraft.com) in bisulfite mode with the following parameters: -r Random -t 240 -h 120 -b 2 -p bisulfite. An in silico chrLambda sequence was used to align the fully methylated lambda sequence that was spiked into the samples in order to measure the bisulfite conversion efficiency and displayed very low non-conversion/ sequencing error rates of 0.00348 (MCF7) and 0.00245 (MCF7-RON/MSP). These rates were used for scoring individual cytosines for significant methylation with a binomial test. A chrPhiX sequence was added to estimate the read quality and a chrAdapter sequence containing all permutations of the adapter sequences was used to remove these artifacts from the data. Differentially-methylated regions (DMRs) were determined by comparing methylation levels in each cell line using a sliding window of 150 base pairs. Overlapping windows passing two thresholds, a Benjamini-Hochberg corrected a chi-square test of independence FDR of < 0.01, and fold difference in methylation of > 2, were merged into continuous DMRs and assigned the best window scores (See http://useq.sourceforge.net/ usageBisSeq.html for details).
Next, DMRs were used to score mean fraction methylation in every sample.
NovoalignBisulfiteParser(http://useq.sourceforge.net/cmdLnMenus.html#Novoali gnBisulfiteParser) was used to parse the text based novoalignments into four binary "PointData" sets containing the number of observed converted Cs (Ts -non methylCs) and non-converted Cs (methylCs) at each reference C sequenced in the genome for both the plus and minus strands.
The PointData was then parsed into mCG context using the ParsePointDataContexts (http://useq.sourceforge.net/cmdLnMenus.html#ParsePointDataContexts) application.
BisStat (http://useq.sourceforge.net/cmdLnMenus.html#BisStat) application was used to calculate per base fraction methylation scores for bases with five or more reads from both strands and generate tracks for visualization in IGB. BisStat also calculated fraction methylation for 500bp windows containing a minimum of 5CpGs.
Mean fraction methylation at each DMR was scored using the ScoreMethylatedRegions(http://useq.sourceforge.net/cmdLnMenus.html#ScoreMethylat edRegions) application. Only regions with a minimum of 5Cs and a minimum read coverage of 5 in all samples were used in further analysis.
Differentially methylated regions were identified using the BisSeq 
RNA-sequencing
Alignments were generated from Illumina Fastq files to the hg19 human genome with all known and theorical splice junctions using Novocraft's novoalign aligner.
NovoalignParser (http://useq.sourceforge.net/cmdLnMenus.html#NovoalignParser) application was used to parse the alignment files into binary point data.
DefineRegionScanSeqs
(http://useq.sourceforge.net/cmdLnMenus.html#DefinedRegionScanSeqs) application was used to define differentially expressed genes.
Sequencing was performed with 3 biological replicates for each cell line. Sequencing reads were aligned to the hg19 human genome with all known and theoretical splice junctions using Novocraft's novoalign aligner.
Pathway and functional analyses of differentially methylated and differentially expressed genes
Differentially expressed genes (p < 0.05) were functionally annotated and classified by using the functional annotation tool database for annotation, visualization, and integrated discovery (DAVID), which provides integrated annotation and analysis of genome-scale datasets derived from high-throughput technologies.
Human breast tumor gene expression data pre-processing
We imported expression data from the referenced studies. Raw data was downloaded from the NCBI GEO website or from websites indicated in the original publications and processed as previously described (Segal el al., 2004) . Briefly, we first log2 transformed the expression values and then calculated the mean expression level for each gene across all samples in a given dataset. These mean values were subtracted from all data points, such that expression was represented relative to the mean of each gene, negative values representing below-mean expression and vice versa. To construct the breast cancer compendium, we first normalized each of the five-included studies independently, and then concatenated these sets. In cases where the same individuals were included in more than one of the eight studies comprising the compendium, such redundancy was eliminated so that each individual was included only once in the compendium. Specifically, individuals of the Uppsala cohort analyzed in the Miller set were eliminated from the Desmedt set.
Analysis of gene-set enrichment patterns
To identify gene-set enrichment patterns we used methods described previously (Segal et al., 2004) , applied using the Genomica software. For each sample (array), we first scored the genes whose expression was at least twofold above or below the mean expression level. We then assessed the fraction of over-or under-expressed genes that belong to each tested gene set, calculating a P value according to the hypergeometric distribution. This was repeated for every sample, using a threshold of P < 0.05 for significant enrichment. To compare enrichment patterns across sample groups, we included clinical annotations for each individual sample (such as tumor grade, size and ER status) derived from the original publications. For all samples showing enrichment for the signature, we calculated the fraction of samples that possessed each annotation, and assigned a P value according to the hypergeometric distribution. We used a more stringent threshold, P < 0.01, for this calculation. Heat maps showing gene-set enrichments in individual samples include only those samples enriched for the signature.
